DCHA Partnering with Howard University to recruit participants for the National COVID Prevention Network Phase 3 vaccine study.

 

The District of Columbia Housing Authority has partnered with Howard University for several health initiatives and is helping recruit participants for the National COVID Prevention Network Phase 3 vaccine study. Phase 3 studies are needed to get reliable answers about safety and effectiveness of the vaccine being studied. If results are good, the new vaccine can be approved for use by the public.

Customers who are interested can volunteer to participate in the study by registering for the vaccine trial at www.coronaviruspreventionnetwork.org or by calling 1-866-288-1919.

The vaccine is the only way out of the pandemic and best method to reduce hospitalizations and mortality rates. Thus, it is especially important for people of color and members from our community to participate in COVID-19 vaccine clinical trials.

Highlights of the study (Participants will get compensated over several visits):

  • The vaccine does not give you COVID-19
  • Randomization 2:1 (2 receive the vaccine and 1 receives the placebo)
  • Study participation presents an opportunity (2 out of 3 chance) to receive the vaccine while awaiting public availability and to be closely monitored by the Howard University Clinical Research Unit (CRU) Team
  • Participants will be consented and will have enough time to ask questions
  • The vaccine is 2 shots 21 days apart

Considerations for who we are looking for to participate (not exhaustive)

Howard is trying to prioritize recruiting people with elevated risk, this can include the following individuals:

  • People with medical conditions, older adults, and people whose job increases their risk of exposure (e.g., retail sales, food service, and )
  • HIV patients can be referred if their CD4 is >200 for 1-2 years and VL <20 can be 30 or 40 but not higher
  • Stable chronic conditions, such as diabetes, HTN, and kidney disease
  • Cancer survivors (if individuals are not actively receiving chemotherapy or radiation)
  • Obese individuals
  • Individuals not on immunosuppressants (steroids, )

Questions about the study and participating? Please contact 202-865-7743 or email HUCOVID@howard.edu.

Ready to participate and register for the vaccine trials? Please visit www.coronaviruspreventionnetwork.org. On the registry form, indicate site-code HOWU for the Howard University vaccine trial. You may also call or by call 1-866-288-1919

Last Modified: 01/14/2021 5:33 pm